Morningside Venture Investments Ltd - 15 Aug 2023 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role: 10%+ Owner
Signature: /s/ Frances Anne Elizabeth Richard, Director
Issuer symbol: AMLX
Transactions as of: 15 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Aug 2023, 17:34:18 UTC
Previous filing: 25 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMLX	Common Stock	Gift	$0	-2,000,000	-29%	$0.000000	4,997,302	15 Aug 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Morningside Venture Investments Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.
F2	Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.